What it is
A chief revenue officer (CRO) is a senior executive responsible for aligning the activities that generate revenue, such as sales, marketing, partnerships, customer success and pricing strategy. In biotech, the role often applies to companies that sell tools, services, diagnostics, platforms or licensed technology to other organizations.
Biotech has its own challenges. Sales cycles can be long, buyers are often scientists, clinicians or procurement teams, and regulatory considerations may shape what can be said and how. A chief revenue officer in biotech typically needs to understand both the science and the commercial side.
A fractional chief revenue officer is an experienced executive who works with a company part-time or on a flexible basis rather than as a full-time employee. Some companies explore this model when they need senior revenue leadership but are not yet ready for a full-time hire. Note that in this context, CRO means chief revenue officer, not a clinical research organization that runs clinical trials.
How it’s traditionally been approached
Many early-stage biotech companies have been led by founders and scientists who handle commercial conversations themselves. Business development or a head of sales may be added as the company grows, often focused on partnerships or licensing.
As companies mature, some hire a full-time chief commercial officer, VP of sales, or chief revenue officer to bring sales, marketing and customer functions under one strategy. This is a significant commitment, and the search can take time.
Other companies rely on advisors, consultants, or board members for commercial guidance. Each path has tradeoffs in cost, availability, depth of involvement and accountability, and the best fit depends on the company's stage and goals.
How the right CRO may help
The right fractional CRO may help a biotech team clarify who its buyers are, how they make decisions, and where the commercial process could be improved. They may also help connect scientific value to a message that customers and partners can understand.
A first conversation is generally an exploratory discussion about your stage, offerings, team and goals. Come prepared to describe your current revenue approach, and expect the CRO to ask questions rather than offer instant answers. Outcomes are never guaranteed.
Good questions to ask include: What experience do you have with companies like mine? How do you structure your involvement? Who would I work with day to day? How do you measure progress? Because CROs in the directory are independent and responsible for their own representations and credentials, verify their background yourself and confirm engagement terms with your own counsel.
The bigger picture
Revenue pressure in biotech can weigh heavily on founders and leaders, who often carry responsibility for investors, employees and a mission they care about. Unclear commercial direction can add stress, while a thoughtful plan may bring more peace of mind.
Taking care of yourself and your team matters during this process. Whatever approach you choose, be patient with the decision and respect your own limits. If you work in healthcare and want resources for your own career or practice, Providers.plus may be one place to explore.
Keep in mind
- Fierce CRO is an independent directory and does not vouch for any individual's experience or qualifications.
- Listing in the directory does not guarantee a match, introduction, hire or business outcome.
- Engagement structures commonly include retainers, a placement fee as a percentage of salary, or a flat access fee, but you should confirm all terms with your own counsel.
- This page is educational and is not legal, tax or employment advice.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
What does a chief revenue officer do in biotech?
A chief revenue officer in biotech oversees the strategy and teams that generate revenue, which may include sales, marketing, partnerships and customer success. The role often bridges scientific value and commercial execution. The exact scope varies by company.
What is a fractional chief revenue officer?
A fractional chief revenue officer is an experienced revenue executive who works with a company on a part-time or flexible basis instead of full-time. Some biotech companies explore this when they want senior guidance without a full-time executive hire. Scope and time commitment are agreed between the parties.
When might a biotech company consider a chief revenue officer?
A biotech company may consider one when it has something to sell but lacks a clear, repeatable commercial approach. This can happen when founders are handling most sales conversations or when sales, marketing and partnerships are not aligned. Every company's timing is different.
Is a chief revenue officer the same as a clinical research organization?
No, a chief revenue officer is an executive who leads revenue growth, while a clinical research organization is a company that supports clinical trials. They share the abbreviation CRO but are entirely different. Fierce CRO focuses on the chief revenue officer meaning.
How does Fierce CRO help me find a biotech chief revenue officer?
Fierce CRO is an independent directory that connects people with educational resources and with independent CROs. It does not guarantee a match, introduction or hire. Each CRO is responsible for their own representations and credentials, so do your own due diligence.
How are chief revenue officers typically engaged?
Engagements are generally described as a retainer, a placement fee based on a percentage of salary, or a flat access fee. Fierce CRO lists a one-time $4,500 fee for 30-day access and a one-time 10% of the CRO's first-year salary placement fee. Confirm all terms with your own counsel before agreeing to anything.
Educational resource. Fierce CRO shares general information and connects people with independent CROs. It is not professional advice. Talk with a qualified professional about your own situation.